Pooled sera from patients with chancroid contain antibodies to a Haemophilus ducreyi antigen with an approximate molecular weight of 28,000 (28K 
Chancroid, caused by the gram-negative coccobacillus Haemophilus ducreyi, is a major sexually transmitted disease in developing countries and occurs sporadically in the United States (5, 33) . Chancroid is a risk factor for human immunodeficiency virus transmission and seroconversion in areas where both infections are endemic (19, 27, 31) . The association between chancroid and human immunodeficiency virus transmission has renewed interest in H. ducreyi pathogenesis, host responses, and the development of specific diagnostic reagents (33) . Identification of immunodominant antigens of H. ducreyi may facilitate the development of reagents to diagnose chancroid. However, antibodies that bind to H. ducreyi frequently cross-react with many species of the family Pasteurellaceae (1, 7, 24, 25) . Absorption of serum samples with lysates of several Haemophilus sp. strains or other bacterial species may remove the cross-reactive antibodies and render serum H. ducreyi specific. For example, pooled chancroid patient sera, absorbed with a Haemophilus sp. strain lysate, bind to an H. ducreyi antigen with an apparent molecular weight of 28,000 or 28,500 (28K or 28.5K), depending on the strain tested (24) . A pool of absorbed sera obtained from people with no history of chancroid does not bind to the 28K or 28.5K antigen, suggesting that the presence of anti-28K or anti-28.5K antibodies represents a specific immune response to H. ducreyi (24) . Animals experimentally infected with H. ducreyi develop an antibody response to H. ducreyi antigens in the 26K to 29K size range (13, 23, 32) . Rabbit polyclonal serum raised to H. ducreyi antigens and absorbed with a mixture of Haemophilus sp., Corynebacterium sp., Escherichia coli, and Candida albicans detects H. ducreyi in clinical specimens obtained from patients with culture-proven chancroid and does not react with lesion material of patients who have other genital ulcer diseases (25) . In Western blot (immunoblot) analyses, the absorbed rabbit antiserum binds to a 28K or 28.5K antigen in each of 450 isolates of H. ducreyi tested (25) . A monoclonal antibody (MAb) also binds to either the 28K or 28.5K antigen in all 450 isolates, indicating that these proteins are antigenically related (8, 25) . Taken together, the data suggest that the 28K and 28.5K proteins may be useful as a serodiagnostic reagent for chancroid or as a target antigen for detection of H. ducreyi.
The 28K or 28.5K membrane protein of H. ducreyi has not been characterized on a molecular level (33) . A gene encoding a 28K H. ducreyi antigen was isolated from an EMBL3 library; however, neither the gene nor its product was characterized (30) . In this study, we report the cloning and sequence characterization of a gene encoding a 28K outer membrane protein (OMP) of H. ducreyi. We also examine the antigenic and physical properties of the 28K OMP and the prevalence of antibodies to this protein in sera from patients with chancroid and other genital ulcer diseases and from healthy subjects.
(This work was presented at the 94th General Meeting of the American Society for Microbiology, Las Vegas, Nev., 1994, and at the 96th General Meeting of the American Society for Microbiology, New Orleans, La., 1996.)
MATERIALS AND METHODS
Bacteria and culture conditions. The 35 isolates of H. ducreyi and all other Haemophilus, Neisseria, Actinobacillus, and Salmonella sp. strains have been described previously (29) . C. albicans ATCC 14053 and Corynebacterium aquaticus ATCC 14665 were obtained from Janet Reynolds, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis. All strains were grown on chocolate agar with 1% IsoVitaleX at 35ЊC in a 5% CO 2 atmosphere as described previously (29) . In some experiments, H. ducreyi was grown in broth consisting of brain heart infusion, 0.1% soluble starch, 50 g of hemin per ml, and 1% IsoVitaleX at 34ЊC. E. coli DH5␣, JM109, and Y1090r Ϫ (Promega Biotech, Madison, Wis.) were grown in Luria-Bertani broth or agar at 37ЊC (17) . Where appropriate, the media were supplemented with ampicillin (50 g/ml). Isolation of outer membranes. H. ducreyi outer membranes were prepared by Sarkosyl extraction of a French press lysate as described previously (29) .
MAbs and sera. BALB/c mice were immunized intraperitoneally with a mixture of H. ducreyi CIP542, 85-023233, and 35000 suspended in phosphate-buffered saline, pH 7.1 (PBS). Hybridomas were established from splenic lymphocytes as described previously (29) . Hybridomas that produced antibodies that recognized H. ducreyi were purified twice by limiting dilution.
Normal human sera obtained from subjects who had no history of chancroid, and sera from patients with proven chancroid, syphilis, or genital herpes, have been described elsewhere (28, 29) .
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), Western blot, and colony blot assays. Whole cells, outer membranes, or purified proteins were solubilized in sample buffer, and the proteins were separated on 12.5 or 15% linear or 4 to 30% gradient polyacrylamide gels by the method of Laemmli (16) . Gels were stained with Coomassie brilliant blue, or the proteins were transferred to nitrocellulose in a Semi-Phor blotter (Hoefer Scientific Instruments, San Francisco, Calif.). For colony blots, organisms were suspended in PBS, applied to nitrocellulose, and dried for 30 min. Western blots and colony blots were probed overnight with MAb 5C9 or serum diluted in 2% nonfat dry milk in PBS. In some experiments, sera were absorbed with a lysate containing H. influenzae, H. parainfluenzae, and H. parahaemolyticus (kindly provided by Cheng-Yen Chen, Centers for Disease Control and Prevention, Atlanta, Ga.) as described previously (7) . In all experiments, the final serum concentration was 1:200. Bound antibody was detected with protein A or goat anti-human immunoglobulin G(␥) coupled to horseradish peroxidase (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) and horseradish peroxidase color development reagent (Bio-Rad Laboratories, Richmond, Calif.).
Immunoelectron microscopy. H. ducreyi cells were collected from a chocolate agar plate and suspended in distilled water. The suspension was placed onto Formvar-coated copper grids and dried. The cells were probed with either MAb 5C9 or Sp2/0-Ag14 tissue culture supernatant, washed, and stained with protein A coupled to 10-nm gold spheres (Sigma Chemical, St. Louis, Mo.). Cells were examined with a Philips CM10 electron microscope (Philips Electronics, Eindhoven, The Netherlands) at 60 kV. The distribution of cells that bound various numbers of gold particles were statistically compared in a nonparametric (MannWhitney U) test as described previously (18) .
Absorption of MAb 5C9 with intact bacteria. Absorption of MAb 5C9 was performed according to a modification of a method described previously (6) . Briefly, MAb 5C9 was diluted in PBS and incubated with either intact H. ducreyi 85-023233 or E. coli y1090r
Ϫ for 1 h. To monitor cell viability, colony counts were performed before and after incubation. Bacteria were removed by centrifugation, and the supernatant was used to probe an H. ducreyi lysate in Western blotting.
DNA manipulation. The genomic gt11 library constructed from H. ducreyi 85-023233 was described previously (4) . Isolation of bacteriophage and plasmid DNA, restriction enzyme digestion, and ligation of plasmid DNA were performed according to standard protocols (17) . E. coli strains were transformed by electroporation in a Cell-Porator equipped with a Voltage Booster (BRL Life Technologies, Grand Island, N.Y.) according to the manufacturer's instructions. Plasmids pGEM3Zf(ϩ) and pGEM7Zf(ϩ) were obtained from Promega Biotech. Plasmid pHD24, which encodes the major pilin subunit of H. ducreyi, was described previously (4) .
DNA sequencing. Both strands of the entire insert of pHD28.5 were sequenced by the dideoxy-chain termination method, using synthetic oligonucleotide primers (Biochemistry Biotechnology Facility, Indiana University School of Medicine, Indianapolis) and the Sequenase version 2.0 sequencing kit (United States Biochemical, Cleveland, Ohio) (26) .
[ 3 H]palmitic acid labeling and globomycin inhibition. Labeling of E. coli proteins was performed according to a modification of the method of Woods et al. (34) . E. coli JM109 transformed with pHD28.5, pHD24, or pGEM3Zf(ϩ) was grown in M9 minimal medium supplemented with 2% Casamino Acids at 37ЊC to early log phase. Two hundred microcuries of [9, 10(n)-3 H]palmitic acid (specific activity, 54 Ci/mmol; Amersham Corporation, Arlington Heights, Ill.) was added, and the cultures were grown for approximately 3 h. The cells were pelleted by centrifugation, suspended in PBS, and lysed by sonication and rapid freeze-thawing. Cellular debris was pelleted at 2,000 ϫ g for 10 min at 4ЊC, and the supernatant was collected. The membrane fraction was obtained by centrifugation of the supernatant at 25,000 ϫ g for 3 h at 4ЊC. Membrane proteins were solubilized, separated by SDS-PAGE, transferred to nitrocellulose, and prepared for autoradiography with En 3 Hance spray (NEN Research Products, Boston, Mass.). The blots were autoradiographed for 8 days at Ϫ70ЊC.
The MIC of globomycin (a kind gift from Janne Cannon, University of North Carolina, Chapel Hill) for H. ducreyi was determined by the broth dilution method (12) . H. ducreyi 35000 was grown overnight in broth. The bacteria were diluted in fresh medium, and globomycin was added at early log phase to a final concentration of 25 g/ml. Incubation of the culture was continued for another 2 h. The cells were harvested and analyzed by Western blotting with MAb 5C9.
PCR and restriction fragment length polymorphism analysis. The open reading frame (ORF) encoding the 28K OMP was amplified from H. ducreyi genomic DNA with synthetic primers and the reagents provided in the GeneAmp kit (Perkin-Elmer, Branchburg, N.J.). Reactions were performed in a GeneAmp PCR System 9600 thermocycler (Perkin-Elmer). Thirty cycles of 94ЊC for 1 min, 60ЊC for 1 min, and 72ЊC for 2 min were used. Amplicons were purified by phenol-chloroform extraction and subjected to restriction digests with PstI and HaeII. Amplicons and digestion products were electrophoresed in 1.8% agarose gels (FMC BioProducts, Rockland, Maine) and visualized by ethidium bromide staining.
Fusion protein expression and purification. The Xpress System kit (Invitrogen Corporation, San Diego, Calif.) was used to express and purify a polyhistidinecontaining 28K OMP fusion protein. The ORF encoding the 28K OMP was amplified from H. ducreyi 35000 genomic DNA by using synthetic primers containing EcoRI sites located 5Ј to the coding sequences, digested with EcoRI, and ligated into EcoRI-digested pRSET B. Following transformation of the recombinant plasmid into E. coli JM109, fusion protein expression was induced by infection with T7 polymerase-expressing M13 phage (Xpress system). Recombinant protein was purified from a cleared lysate by using ProBond Columns and the native buffer system provided in the kit. Fractions were analyzed by SDS-PAGE and Western blotting, and those that bound to MAb 5C9 were pooled. Fractions were dialyzed overnight against PBS in 10 10K-cutoff Slidalyzers (Pierce, Rockford, Ill.) and concentrated with a Centricon-10 microconcentrator (Amicon Corp., Beverly, Mass.).
Nucleotide sequence accession number. The sequence of hlp will appear under GenBank accession number U57817.
RESULTS
Binding of MAb 5C9 to H. ducreyi. In colony blots, MAb 5C9 bound to all 35 H. ducreyi strains tested but did not bind to C. albicans, C. aquaticus, or any other members of the families Pasteurellaceae, Neisseriaceae, and Enterobacteriaceae (Table  1) . In Western blot analysis, MAb 5C9 bound to a 28K or 28.5K protein in 10 isolates with diverse geographic origins (Fig. 1) . MAb 5C9 also bound a 28K protein in a Sarkosylinsoluble fraction of H. ducreyi (Fig. 1) . These data suggested that MAb 5C9 bound to a species-specific epitope and that the 28K protein was localized to the outer membrane. Surface exposure of the MAb 5C9 epitope. In immunoelectron microscopy, H. ducreyi 35000 cells exhibited variable binding of gold spheres when probed with MAb 5C9 (Fig. 2) . Little to no binding was observed when Sp2/0-Ag14 was used as a probe (Fig. 2) . The number of gold spheres that bound to each of 100 H. ducreyi 85-023233 cells after incubation with MAb 5C9 was statistically compared with the number obtained with the Sp2/0-Ag14 control (29) . When probed with MAb 5C9, 3 cells had heavy (Ն20 spheres), 12 cells had moderate (6 to 19 spheres), and 85 cells had low (0 to 5 spheres) binding. The 100 cells that were probed with Sp2/0-Ag14 bound no spheres or one sphere. The level of MAb 5C9 surface labeling was significantly greater than that of the Sp2/0-Ag14 control (MannWhitney U test; P ϭ 0.0001). To confirm that the 5C9 epitope was surface exposed, MAb 5C9 was incubated with intact bacteria and then used to probe H. ducreyi in Western blot analysis. Absorption with H. ducreyi abolished the reactivity of MAb 5C9, while absorption with E. coli had no effect on MAb 5C9 binding (data not shown). Colony counts showed no loss of bacterial viability during the absorption procedure, indicating that MAb 5C9 was not binding to an epitope exposed upon lysis of the bacteria. Thus, the 5C9 epitope was surface exposed by two criteria.
Cloning and sequence analysis of the gene encoding the 28K OMP. Approximately 3,000 plaques of an H. ducreyi gt11 genomic library were screened with MAb 5C9, and 9 positive plaques were identified. A 4.1-kb insert from one of the positive phages was ligated into pGEM7Zf(ϩ) and designated pHD28. A 1.3-kb HindIII-ClaI fragment was subcloned from pHD28 into pGEM3Zf(ϩ) to generate pHD28.5. E. coli DH5␣ transformed with pHD28 or pHD28.5 expressed a 28K protein and a protein of approximately 18K that bound to MAb 5C9 (Fig. 3) . Although pHD28.5 expressed two proteins that bound 5C9, the sequence of the 1,314-bp insert of pHD28.5 contained a single complete 626-bp ORF (Fig. 4) . The ORF was preceded by Ϫ10 and Ϫ35 regions and a ribosome binding site and was followed by an imperfect inverted repeat, indicative of a factorindependent termination signal (14) . The predicted polypeptide encoded by the ORF was approximately 23K and contained a putative leader peptide with a signal peptidase II cleavage site (21) . The data suggested that the 28K OMP was a lipoprotein, and the gene was designated hlp, for H. ducreyi lipoprotein. The 18K species most likely was encoded by hlp and probably represents a breakdown product. Some lipoproteins migrate aberrantly in SDS-PAGE (35) , and this may account for the discrepancy between the predicted molecular weight of the mature protein (21K) and its apparent molecular weight in SDS-PAGE (28K).
[ (Fig. 5) . The 30K band probably represented unprocessed Hlp (15), and its detection confirmed the presence of a signal peptidase II-like enzyme in H. ducreyi (28) .
Homologies and conservation of hlp.
A BLAST algorithm search (3) of the PDB, Swiss-Prot, PIR, and GenBank databases found no homologies to either hlp or the predicted Hlp amino acid sequence. No homologies to hlp were found in the H. influenzae Rd genome (9).
Genomic DNA from 10 H. ducreyi isolates with diverse geographic origins and from E. coli JM109 were amplified by PCR with primers 1 and 2 (Fig. 4) . Amplicons of the expected size were obtained from all 10 of the H. ducreyi isolates. Nine of the ten amplicons yielded identical restriction fragments when digested with either PstI or HaeII (Fig. 6) . One amplicon, generated from the Kenyan isolate 33921, was repeatedly resistant to PstI digestion and had a unique HaeII digestion pattern (Fig. 6, lane 10) . This isolate also expressed the 28.5K form of Hlp (Fig. 1, lane 2) . The data suggested that the divergence in hlp among strains of H. ducreyi correlated with the expression of the 28K or 28.5K form of Hlp.
Presence of antibodies to Hlp in human sera. A recombinant form of mature Hlp was purified and analyzed by Western blotting with human sera. Sera from eight patients with chancroid, two patients with genital herpes, three patients with syphilis, and six healthy volunteers with no history of chancroid contained antibodies to recombinant Hlp (Fig. 7) . Although patients with chancroid generally had stronger reactivity to recombinant Hlp than patients with other genital ulcer diseases or normal subjects, sera from individuals without a history of chancroid sometimes had strong reactivity (Fig. 7) . Anti-Hlp antibodies were not completely absorbed from any of the sera by a Haemophilus sp. strain lysate (data not shown). These data indicated that the presence of antibodies to Hlp in serum may not correlate with a history of H. ducreyi infection.
DISCUSSION
All isolates of H. ducreyi tested expressed a 28K or 28.5K OMP that contained an epitope defined by MAb 5C9. MAb 5C9 did not bind to any other species tested. The gene encoding the 28K OMP, designated hlp, was isolated from an H. ducreyi genomic library. BLAST and H. influenzae Rd database searches found no homologies to hlp or the predicted Hlp amino acid sequence. Taken together, these data suggest that MAb 5C9 binds to an epitope that was species specific and that Hlp is conserved among H. ducreyi isolates.
Immunoelectron microscopy indicated that MAb 5C9 bound variably to a surface-exposed epitope. Antibody binding may have been affected by degradation of Hlp, phase variation of Hlp or other bacterial surface components, or fixation of cells to the hydrophobic surface by drying. Absorption experiments confirmed that the MAb 5C9 epitope was surface exposed. Although the cause of the variable binding of MAb 5C9 in immunoelectron microscopy is unclear, similar results have been described for other surface-exposed epitopes in H. ducreyi and other organisms (18, 29) .
The predicted leader peptide of Hlp contained a consensus signal peptidase II processing site. When grown in the presence of [ 3 H]palmitate, E. coli containing hlp expressed a novel, labeled 28K protein. In H. ducreyi, Hlp processing was sensitive to the signal peptidase II inhibitor globomycin. These data indicate that Hlp is a lipoprotein and that H. ducreyi possesses an enzyme similar to E. coli signal peptidase II, as we have reported previously (28) .
A feature of the predicted amino acid sequence of processed Hlp is the presence of aspartate and lysine residues at the ϩ2 and ϩ3 positions (Fig. 4) . A ϩ2 aspartate leads to the sorting of lipoproteins to the inner membrane in E. coli (20, 36) . However, site-specific mutations in the leader peptide of the Braun lipoprotein show that sorting of lipoproteins is also influenced by the identity of the amino acid in the ϩ3 position (10). For example, constructs containing ϩ2 aspartate, ϩ3 serine localize to the inner membrane while proteins containing a ϩ2 aspartate, ϩ3 lysine are sorted to both the inner and outer membrane (10) . Alternatively, Hlp may be analogous the Klebsiella pneumoniae lipoprotein pullulanase, which also contains a ϩ2 aspartate (22) . Pullulanase is sorted to the inner membrane, where it engages specific secretion factors that mediate the transport of the protein through the outer membrane to the cell surface (20, 21 (1, 2, 28, 29) . Cross-reacting antibodies to H. ducreyi are believed to arise in response to colonization or infection of the host by other microorganisms (28) . Anti-Hlp antibodies in individuals with no history of chancroid probably arise in a similar manner, indicating the existence of an organism(s) that expresses an antigen(s) that is antigenically similar to Hlp. These organisms need to be identified and included in absorbents if Hlp is to be used as the target in diagnostic procedures that require serum.
In summary, we have described an H. ducreyi outer membrane lipoprotein that contains a species-specific epitope. We conclude that despite the observation that Hlp has no homology to the sequences in present databases, Hlp-like protein(s) may exist in other organisms and could reduce the specificity and sensitivity of Hlp-based diagnostic reagents for chancroid. Future studies will include the construction and evaluation of an Hlp deletion mutant and evaluation of the biological effect of anti-Hlp antibodies on H. ducreyi. FIG. 7 . Western blot of purified recombinant Hlp probed with MAb 5C9 or with human sera. Lane 1 was probed with MAb 5C9; lanes 2 to 9 were probed with sera from patients with chancroid; lanes 10 and 11 were probed with sera from patients with genital herpes; lanes 12 to 14 were probed with sera from patients with syphilis; lanes 15 to 20 were probed with sera from volunteers with no history of chancroid. The relative migration of molecular markers is shown on the left.
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